Given the close relationship between tau deposition, impaired cognition and neuronal injury, tau-PET is able to provide significant additive information to clinical diagnosis and amyloid-PET imaging and offers a complementary tool to help in discriminating between different pathologies, and possibly, between different tauopathies. The gene discussed is MAPT; the disease is amyloidosis.